© 2008 Oxford University Press
This article appears in the following Nucleic Acid Symposium Series issue: Joint Symposium of the 18th International Roundtable on Nucleosides, Nucleotides and Nucleic Acids and the 35th International Symposium on Nucleic Acids Chemistry [View the issue table of contents]
Base-Modified Ribonucleosides as Potential Anti-Hepatitis C virus Agents
1Engelhardt Institute of Molecular Biology RAS, 119991 Moscow, Russia; 2University of Oslo, Centre for MedicalStudies in Russia, Moscow, Russia
*Corresponding Author. E-mail: ala2004_07{at}mail.ru
Abstract
Four novel series of base modified ribonucleoside analogues were synthesized and evaluated as potential anti-HCV agents. For two compounds notable anti-HCV activity was obserwed The triphosphates of bicyclic pyrimidine ribonucleosides were studied as substrates/inhibitors of HCV RNA-dependent RNA polymerase (RdRp, NS5B protein) and RNA helicase/NTPase (NS3 protein).